These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5394875)

  • 1. Influenza immunization. A new vaccine.
    Cromwell HA; Brandon FB; McLean IW; Sadusk JF
    JAMA; 1969 Nov; 210(8):1438-42. PubMed ID: 5394875
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 3. [Field trial with a new type of influenza subunit vaccine (author's transl)].
    Kunz C; Hofmann H
    Wien Klin Wochenschr; 1976 Aug; 88(15):504-8. PubMed ID: 997532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man.
    Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS; Hierholzer JC
    Am J Epidemiol; 1970 Oct; 92(4):248-56. PubMed ID: 5458217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity and protective efficacy of influenza vaccination.
    Hannoun C; Megas F; Piercy J
    Virus Res; 2004 Jul; 103(1-2):133-8. PubMed ID: 15163501
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization against influenza. Prevention of illness in man by aerosolized inactivated vaccine.
    Waldman RH; Mann JJ; Small PA
    JAMA; 1969 Jan; 207(3):520-4. PubMed ID: 5818213
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary results of oral influenza vaccination with live attenuated viruses.
    DeBarbieri A; Crovari P; Cuneo-Crovari P; Badolati G; Giacometti G
    Dev Biol Stand; 1976; 33():213-9. PubMed ID: 782972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A/H1N1 influenza vaccination in patients with systemic lupus erythematosus: safety and immunity.
    Lu CC; Wang YC; Lai JH; Lee TS; Lin HT; Chang DM
    Vaccine; 2011 Jan; 29(3):444-50. PubMed ID: 21078406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza antibody response following aerosal administration of inactivated virus.
    Waldman RH; Wood SH; Torres EJ; Small PA
    Am J Epidemiol; 1970 Jun; 91(6):574-85. PubMed ID: 5445644
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response after a single dose of an AS03-adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients.
    Meyer S; Adam M; Schweiger B; Ilchmann C; Eulenburg C; Sattinger E; Runte H; Schlüter M; Deuse T; Reichenspurner H; Costard-Jäckle A
    Transplantation; 2011 May; 91(9):1031-5. PubMed ID: 21358365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on live influenza virus vaccine. II. Evaluation of cold-adapted influenza A2 Hong Kong virus in volunteers (author's transl)].
    Mizutani H; Izuchi T
    Uirusu; 1973 Jun; 23(2):141-7. PubMed ID: 4808070
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjuvanted or whole-virion vaccine for 2009 influenza A (H1N1).
    Barrett PN; Ehrlich HJ
    Lancet Infect Dis; 2011 Jul; 11(7):496-7; author reply 497-8. PubMed ID: 21700237
    [No Abstract]   [Full Text] [Related]  

  • 17. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 19. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.